These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4349149)

  • 1. Participation of macrophages in tumor immunity.
    Tevethia SS; Zarling JM
    Natl Cancer Inst Monogr; 1972 Dec; 35():279-82. PubMed ID: 4349149
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40.
    Tevethia SS; Tevethia MJ
    Prog Med Virol; 1975; 21():103-17. PubMed ID: 174151
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):149-57. PubMed ID: 4348219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 6. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo activity of cytotoxic lymphocytes.
    Cerottini JC; Freedman LR; Brunner KT
    Transplant Proc; 1972 Sep; 4(3):299-301. PubMed ID: 4404149
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell interactions in adoptive immune rejection of a syngeneic tumor.
    Howell SB; Dean JH; Esber EC; Llaw LW
    Int J Cancer; 1974 Nov; 14(5):662-74. PubMed ID: 4376531
    [No Abstract]   [Full Text] [Related]  

  • 10. Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cells.
    Lejeune FJ
    Yale J Biol Med; 1973 Dec; 46(5):368-83. PubMed ID: 4205114
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultraviolet radiation and tumor immunity.
    Kripke ML
    J Reticuloendothel Soc; 1977 Sep; 22(3):217-22. PubMed ID: 926083
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
    Law LW
    Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
    [No Abstract]   [Full Text] [Related]  

  • 15. The gordian knot of tumour immunology.
    Amlot P
    Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition and destruction of target cells by tumoricidal macrophages.
    Fidler IJ
    Isr J Med Sci; 1978 Jan; 14(1):177-91. PubMed ID: 204610
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of the immune response to transplantation antigens. V. A comparison of the effects of antilymphocytic serum and enhancing alloantiserum on effector mechanisms of allograft rejection.
    Zola H
    Clin Exp Immunol; 1975 Feb; 19(2):367-76. PubMed ID: 1212805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells.
    Monach PA; Schreiber H; Rowley DA
    Transplantation; 1993 Jun; 55(6):1356-61. PubMed ID: 8100090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.